Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Biomedicines
2023 Jan 12;111:. doi: 10.3390/biomedicines11010196.
Show Gene links
Show Anatomy links
Esterification of p-Coumaric Acid Improves the Control over Melanoma Cell Growth.
Carmo-Martins JI
,
Gonzatti MB
,
Varela MT
,
Sousa MEP
,
Costa LVS
,
Rodrigues EG
,
Fernandes JPS
,
Keller AC
.
Abstract
Previous studies reported that p-coumaric acid modulates melanoma growth. Because the esterification of p-coumaric acid (p-CA) enhanced its activity as an antimelanogenic agent, we aimed to determine the antitumor potential of two derivatives, the ethyl and butyl esters, against the murine B16-F10 and the human SK-MEL-25 melanoma cells. Cell viability was determined in vitro by the lactate dehydrogenase release and violet crystal absorption assays. The cell proliferation rate and cell cycle behavior were determined by the colony formation assay and flow cytometry analysis. Although p-CA, at the concentration of 1 mM, failed to exert a significant antitumor activity, the ethyl and butyl ester derivatives caused substantial tumor cell death at doses < 1 mM. Despite a reduction in their direct cytotoxicity at minor doses, both products controlled the melanoma growth by arresting the cell cycle at the G0/G1 (B16-F10) or S/G2 (SK-MEL-25). Furthermore, the in vivo experiments showed that the butyl ester derivative suppressed the lung B16-F10 burden, compared to the p-CA-treated mice. Thus, the esterification of p-coumaric acid improved the control over the proliferation of murine and human melanoma cells and can be considered an approach for designing novel anticancer agents.
Finance code 001 Coordenação de Aperfeicoamento de Pessoal de Nível Superior, 308964/2019-5 and 306355/2018-3 CNPq, 2019/11490-5 2019/24028-8 2018/03918-2 2021/11200-7 São Paulo Research Foundation (FAPESP)
Aguiar,
In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments.
2019, Pubmed
Aguiar,
In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments.
2019,
Pubmed
Arruda,
Effect of light, oxygen and temperature on the stability of artepillin C and p-coumaric acid from Brazilian green propolis.
2020,
Pubmed
Borrego,
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
1999,
Pubmed
Cibrián,
CD69: from activation marker to metabolic gatekeeper.
2017,
Pubmed
Darzynkiewicz,
Determining cell cycle stages by flow cytometry.
2001,
Pubmed
Davis,
Material deprivation and access to cancer care in a universal health care system.
2020,
Pubmed
Feoktistova,
Crystal Violet Assay for Determining Viability of Cultured Cells.
2016,
Pubmed
Ferreira,
BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity.
2016,
Pubmed
Gastaldello,
Green Propolis Compounds (Baccarin and p-Coumaric Acid) Show Beneficial Effects in Mice for Melanoma Induced by B16f10.
2021,
Pubmed
Harvey,
The re-emergence of natural products for drug discovery in the genomics era.
2015,
Pubmed
Hu,
The Anti-tumor Effects of p-Coumaric Acid on Melanoma A375 and B16 Cells.
2020,
Pubmed
Janicke,
The antiproliferative effect of dietary fiber phenolic compounds ferulic acid and p-coumaric acid on the cell cycle of Caco-2 cells.
2011,
Pubmed
Kianmehr,
Low-level laser irradiation potentiates anticancer activity of p-coumaric acid against human malignant melanoma cells.
2020,
Pubmed
Kilani-Jaziri,
Immunomodulatory and cellular anti-oxidant activities of caffeic, ferulic, and p-coumaric phenolic acids: a structure-activity relationship study.
2017,
Pubmed
Massaro,
Inhibition of proliferation and invasion in 2D and 3D models by 2-methoxyestradiol in human melanoma cells.
2017,
Pubmed
Nunes,
Socioeconomic inequalities in the access to and quality of health care services.
2014,
Pubmed
Pragasam,
Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats.
2013,
Pubmed
Remnant,
The intrinsically disorderly story of Ki-67.
2021,
Pubmed
Sarna,
Melanin presence inhibits melanoma cell spread in mice in a unique mechanical fashion.
2019,
Pubmed
Schwartz,
Targeting the cell cycle: a new approach to cancer therapy.
2005,
Pubmed
Siegel,
Cancer statistics, 2019.
2019,
Pubmed
Sobecki,
Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels.
2017,
Pubmed
Stege,
The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges.
2021,
Pubmed
Varela,
Coumaric acid derivatives as tyrosinase inhibitors: Efficacy studies through in silico, in vitro and ex vivo approaches.
2020,
Pubmed
Wani,
Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia.
1971,
Pubmed
